Proximare

Proximare is a specialty pharmaceutical company that leverages the 505(b)(2) regulatory pathway to develop improved versions of existing therapeutic agents. The company focuses on therapeutic areas such as central nervous system (CNS) disorders, pain management, and oncology, utilizing advanced drug delivery technologies to enhance the efficacy and safety of established drugs. Proximare's business model is centered on a lean, virtual R&D approach, where it identifies high-potential assets for reformulation and partners with larger pharmaceutical firms for late-stage development and commercialization. The leadership team brings extensive experience from pioneering drug delivery companies like Alza and Depomed.